ClinicalTrials.Veeva

Menu

Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

Daiichi Sankyo logo

Daiichi Sankyo

Status and phase

Completed
Phase 4

Conditions

Hypertension

Treatments

Drug: Olmesartan medoxomil
Drug: Benazepril
Drug: Amlodipine
Drug: Hydroclorothiazide

Study type

Interventional

Funder types

Industry

Identifiers

NCT00185120
866-447

Details and patient eligibility

About

A comparison of 2 different combinations of high blood pressure medications to treat hypertension

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Greater than 18 years of age
  • Patients with high blood pressure

Exclusion criteria

  • Hypertensive encephalopathy, stroke or transient ischemic attack within the past 6 months
  • History of myocardial infarction, percutaneous transluminal coronary revascularization, coronary artery bypass graft, and/or unstable angina pectoris within the past 6 months
  • Type 1 diabetes mellitus

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

20

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems